Literature DB >> 22231454

Synergistic effect between two bacteriocin-like inhibitory substances produced by Lactobacilli Strains with inhibitory activity for Streptococcus agalactiae.

Francisco O Ruíz1, Gisela Gerbaldo, María J García, Walter Giordano, Liliana Pascual, Isabel L Barberis.   

Abstract

Group B streptococci (GBS) are bacterial species that colonize the vagina in pregnant women and as such may cause serious infections in neonates that passed through the birth channel. The objective of this work was to study the inhibitory activities produced by each bacteriocin-like inhibitory substance (BLIS) of Lactobacillus rhamnosus L60 and Lactobacillus fermentum L23, and the effects of the combined BLIS-es of these lactobacilli on GBS. The interactions between the BLIS-es were assessed by qualitative and quantitative methods on agar plates. The minimum inhibitory concentrations (MICs) and fractional inhibitory concentrations (FICs) were determined by a modification of the broth microdilution and checkerboard methods, respectively. Antibiotic susceptibilities of all S. agalactiae strains were assayed and the results of these tests were evaluated for statistical significance. A 7.5% of GBS isolates were recovered from 760 pregnant women and 91% of those strains were susceptible to each BLIS produced by L. fermentum, L. rhamnosus, and also to a mixture of them. The comparisons among the BLIS-es showed statistically significant differences, with a combination of the BLIS-es from the two Lactobacillus species being better than the BLIS of each one alone (P < 0.05) as GBS growth inhibitors. Synergistic activities between the BLIS-es were found on 100% of susceptible GBS strains, MICs ranges of BLIS of L23 and L60 were 80-160 and 160-320 UA ml(-1), respectively. By the checkerboard method, the BLIS-es combination showed synergistic effect on all sensitive strains tested, with values of FICs ranging from 0.131 to 0.218. The BLIS-es produced by these lactobacilli of vaginal origin were able to inhibit S. agalactiae isolates. The results indicate that these strains may have probiotic potential for the control of GBS in women and may consequently prevent GBS infections in newborns.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22231454     DOI: 10.1007/s00284-011-0077-0

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  27 in total

1.  Invasive group B streptococcal disease in nonpregnant adults.

Authors:  M Bolaños; A Cañas; O E Santana; J L Pérez-Arellano; I de Miguel; A M Martín-Sánchez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-11       Impact factor: 3.267

2.  Species differentiation of human vaginal lactobacilli.

Authors:  M ROGOSA; M E SHARPE
Journal:  J Gen Microbiol       Date:  1960-08

3.  In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis.

Authors:  Peter J Petersen; Ponpen Labthavikul; C Hal Jones; Patricia A Bradford
Journal:  J Antimicrob Chemother       Date:  2006-01-23       Impact factor: 5.790

4.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

Review 5.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Temperature-dependent variation in API 50 CH fermentation profiles of Lactobacillus species.

Authors:  A Nigatu; S Ahrné; G Molin
Journal:  Curr Microbiol       Date:  2000-07       Impact factor: 2.188

7.  Rapid and low-level toxic PCR-based method for routine identification of Flavobacterium psychrophilum.

Authors:  C Cepeda; Y Santos
Journal:  Int Microbiol       Date:  2000-12       Impact factor: 2.479

8.  Antimicrobial activity, inhibition of urogenital pathogens, and synergistic interactions between lactobacillus strains.

Authors:  Francisco O Ruiz; Gisela Gerbaldo; Paula Asurmendi; Liliana M Pascual; Walter Giordano; Isabel L Barberis
Journal:  Curr Microbiol       Date:  2009-11       Impact factor: 2.188

9.  [Group B Streptococcus carriers among pregnant women].

Authors:  S D García; M Cora Eliseth; M J Lazzo; E Copolillo; A D Barata; R de Torres; C A Vay; A M Famiglietti
Journal:  Rev Argent Microbiol       Date:  2003 Oct-Dec       Impact factor: 1.852

10.  Group B streptococcal antibiotic resistance patterns in pregnant women.

Authors:  Robert J Stiller; Linda Padilla; Ronika Choudhary; Thomas Tinghitella; Steven Laifer
Journal:  Conn Med       Date:  2003 Jun-Jul
View more
  15 in total

1.  Identification of vaginal lactobacilli with potential probiotic properties isolated from women in North Lebanon.

Authors:  Imad Al Kassaa; Monzer Hamze; Didier Hober; Nour-Eddine Chihib; Djamel Drider
Journal:  Microb Ecol       Date:  2014-02-19       Impact factor: 4.552

2.  Group B Streptococcus CovR regulation modulates host immune signalling pathways to promote vaginal colonization.

Authors:  Kathryn A Patras; Nai-Yu Wang; Erin M Fletcher; Courtney K Cavaco; Alyssa Jimenez; Mansi Garg; Joshua Fierer; Tamsin R Sheen; Lakshmi Rajagopal; Kelly S Doran
Journal:  Cell Microbiol       Date:  2013-01-30       Impact factor: 3.715

3.  Protease-Sensitive Inhibitory Activity of Cell-free Supernatant of Lactobacillus crispatus 156 Synergizes with Ciprofloxacin, Moxifloxacin and Streptomycin Against Pseudomonas aeruginosa: An In Vitro Study.

Authors:  Sukhraj Kaur; Preeti Sharma
Journal:  Probiotics Antimicrob Proteins       Date:  2015-06       Impact factor: 4.609

4.  Effect of two probiotic strains of Lactobacillus on in vitro adherence of Listeria monocytogenes, Streptococcus agalactiae, and Staphylococcus aureus to vaginal epithelial cells.

Authors:  L Ortiz; F Ruiz; L Pascual; L Barberis
Journal:  Curr Microbiol       Date:  2014-01-28       Impact factor: 2.188

Review 5.  Is there a role for probiotics in the prevention of preterm birth?

Authors:  Siwen Yang; Gregor Reid; John R G Challis; Sung O Kim; Gregory B Gloor; Alan D Bocking
Journal:  Front Immunol       Date:  2015-02-17       Impact factor: 7.561

6.  Effect of Eugenol against Streptococcus agalactiae and Synergistic Interaction with Biologically Produced Silver Nanoparticles.

Authors:  Renata Perugini Biasi-Garbin; Eliane Saori Otaguiri; Alexandre Tadachi Morey; Mayara Fernandes da Silva; Ana Elisa Belotto Morguette; César Armando Contreras Lancheros; Danielle Kian; Márcia Regina Eches Perugini; Gerson Nakazato; Nelson Durán; Celso Vataru Nakamura; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-07       Impact factor: 2.629

7.  Evaluation of CAMP-Like Effect, Biofilm Formation, and Discrimination of Candida africana from Vaginal Candida albicans Species.

Authors:  Keyvan Pakshir; Mahboubeh Bordbar; Kamiar Zomorodian; Hasti Nouraei; Hossein Khodadadi
Journal:  J Pathog       Date:  2017-11-26

Review 8.  Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease.

Authors:  Julia Kolter; Philipp Henneke
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

Review 9.  Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches.

Authors:  Kathryn A Patras; Victor Nizet
Journal:  Front Pediatr       Date:  2018-02-22       Impact factor: 3.418

Review 10.  Acid Stress Response Mechanisms of Group B Streptococci.

Authors:  Sarah Shabayek; Barbara Spellerberg
Journal:  Front Cell Infect Microbiol       Date:  2017-09-07       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.